drugset / Trial / NCT02452255
Fenofibrate and Propranolol in Burn Patients
Phase 2/3
Terminated
18 enrolled
The University of Texas Medical Branch, Galveston
National Institute of General Medical Sciences (NIGMS) · collabShriners Hospitals for Children · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The proposed study will test the hypothesis that Propranolol, fenofibrate and fenofibrate plus propranolol have therapeutic, physiological, and metabolic effects that will improve clinical outcomes, and the long-term recovery, rehabilitation, and QOL in burned patients.
Timeline
- Start
- 2015-11
- Primary completion
- 2018-12
- Completion
- 2019-07-12
Outcome
Outcome not reported
Stopped: “Shriner's Burn Hospital closed the study and access to study-related data is unavailable. We are unable to submit the additional information or results-data”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Fenofibrate | Small molecule | — | Oral |
| Comparator | Propranolol | Small molecule | — | Oral |
Indications
No indication recorded.